BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37544076)

  • 1. Neutrophil to lymphocyte ratio and antidepressant treatment response in patients with major depressive disorder: Effect of sex and hippocampal volume.
    Paolini M; Harrington Y; Raffaelli L; Poletti S; Zanardi R; Colombo C; Benedetti F
    Eur Neuropsychopharmacol; 2023 Nov; 76():52-60. PubMed ID: 37544076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
    Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
    Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-lymphocyte Ratio and C-reactive Protein Level in Patients with Major Depressive Disorder Before and After Pharmacotherapy.
    Adhikari A; Dikshit R; Karia S; Sonavane S; Shah N; De Sousa A
    East Asian Arch Psychiatry; 2018 Jun; 28(2):53-58. PubMed ID: 29921741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal volume as treatment predictor in antidepressant naïve patients with major depressive disorder.
    Zarate-Garza PP; Ortega-Balderas JA; Ontiveros-Sanchez de la Barquera JA; Lugo-Guillen RA; Marfil-Rivera A; Quiroga-Garza A; Guzman-Lopez S; Elizondo-Omaña RE
    J Psychiatr Res; 2021 Aug; 140():323-328. PubMed ID: 34126427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.
    Nogovitsyn N; Muller M; Souza R; Hassel S; Arnott SR; Davis AD; Hall GB; Harris JK; Zamyadi M; Metzak PD; Ismail Z; Downar J; Parikh SV; Soares CN; Addington JM; Milev R; Harkness KL; Frey BN; Lam RW; Strother SC; Rotzinger S; Kennedy SH; MacQueen GM
    Neuropsychopharmacology; 2020 Jan; 45(2):283-291. PubMed ID: 31610545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
    Maller JJ; Broadhouse K; Rush AJ; Gordon E; Koslow S; Grieve SM
    Mol Psychiatry; 2018 Aug; 23(8):1737-1744. PubMed ID: 29133948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal volume and the rapid antidepressant effect of ketamine.
    Abdallah CG; Salas R; Jackowski A; Baldwin P; Sato JR; Mathew SJ
    J Psychopharmacol; 2015 May; 29(5):591-5. PubMed ID: 25122038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder.
    Katsuki A; Watanabe K; Nguyen L; Otsuka Y; Igata R; Ikenouchi A; Kakeda S; Korogi Y; Yoshimura R
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder.
    Paolini M; Fortaner-Uyà L; Lorenzi C; Spadini S; Maccario M; Zanardi R; Colombo C; Poletti S; Benedetti F
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder.
    Zhou YL; Wu FC; Wang CY; Zheng W; Lan XF; Deng XR; Ning YP
    J Affect Disord; 2020 Nov; 276():608-615. PubMed ID: 32871692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smaller hippocampal volumes predict lower antidepressant response/remission rates in depressed patients: A meta-analysis.
    Colle R; Dupong I; Colliot O; Deflesselle E; Hardy P; Falissard B; Ducreux D; Chupin M; Corruble E
    World J Biol Psychiatry; 2018 Aug; 19(5):360-367. PubMed ID: 27376473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study.
    Paolini M; Harrington Y; Colombo F; Bettonagli V; Poletti S; Carminati M; Colombo C; Benedetti F; Zanardi R
    J Psychopharmacol; 2023 Nov; 37(11):1070-1081. PubMed ID: 37589290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio.
    Ekinci O; Ekinci A
    Nord J Psychiatry; 2017 Nov; 71(8):574-580. PubMed ID: 28800269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder.
    Puangsri P; Jinanarong V; Ninla-Aesong P
    J Psychiatr Res; 2023 Jan; 157():26-35. PubMed ID: 36436425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted topology of hippocampal connectivity is associated with short-term antidepressant response in major depressive disorder.
    Gong L; Hou Z; Wang Z; He C; Yin Y; Yuan Y; Zhang H; Lv L; Zhang H; Xie C; Zhang Z
    J Affect Disord; 2018 Jan; 225():539-544. PubMed ID: 28866298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder.
    Zhang J; Yue Y; Thapa A; Fang J; Zhao S; Shi W; Yang Z; Li Y; Yuan Y
    J Affect Disord; 2019 May; 250():432-438. PubMed ID: 30878656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress, inflammation and treatment response in major depression.
    Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential usefulness of complete blood count parameters and inflammatory ratios as simple biomarkers of depression and suicide risk in drug-naive, adolescents with major depressive disorder.
    Puangsri P; Ninla-Aesong P
    Psychiatry Res; 2021 Nov; 305():114216. PubMed ID: 34571404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.